Byambasuren, A.; Gyarvuulkhasuren, B.; Erdenebat, B.; Nyamdavaa, K.; Baatarkhuu, O.
Long-Term Outcomes of Ledipasvir/Sofosbuvir Treatment in Hepatitis C: Viral Suppression, Hepatocellular Carcinoma, and Mortality in Mongolia. Viruses 2025, 17, 743.
https://doi.org/10.3390/v17060743
AMA Style
Byambasuren A, Gyarvuulkhasuren B, Erdenebat B, Nyamdavaa K, Baatarkhuu O.
Long-Term Outcomes of Ledipasvir/Sofosbuvir Treatment in Hepatitis C: Viral Suppression, Hepatocellular Carcinoma, and Mortality in Mongolia. Viruses. 2025; 17(6):743.
https://doi.org/10.3390/v17060743
Chicago/Turabian Style
Byambasuren, Amgalan, Buyankhishig Gyarvuulkhasuren, Byambatsogt Erdenebat, Khurelbaatar Nyamdavaa, and Oidov Baatarkhuu.
2025. "Long-Term Outcomes of Ledipasvir/Sofosbuvir Treatment in Hepatitis C: Viral Suppression, Hepatocellular Carcinoma, and Mortality in Mongolia" Viruses 17, no. 6: 743.
https://doi.org/10.3390/v17060743
APA Style
Byambasuren, A., Gyarvuulkhasuren, B., Erdenebat, B., Nyamdavaa, K., & Baatarkhuu, O.
(2025). Long-Term Outcomes of Ledipasvir/Sofosbuvir Treatment in Hepatitis C: Viral Suppression, Hepatocellular Carcinoma, and Mortality in Mongolia. Viruses, 17(6), 743.
https://doi.org/10.3390/v17060743